Top Section
Explore Business Standard
Top Section
Explore Business Standard
Don’t miss the latest developments in business and finance.
Book Building
₹ 152.46
₹ 140
105
₹ 14,700.00
MumbaiNSE
27-Sep-2023
03-Oct-2023
06-Oct-2023
| 1 Week | -2.89 |
| 1 Month | 6.50 |
| 3 Month | -2.32 |
| 6 Month | -20.96 |
| 1 Year | -34.25 |
Initial public offer of up to 10,890,000 equity shares of face value of Rs. 10 each (Equity Shares) of Valiant Laboratories Limited (Company or Issuer) for cash at a price of Rs. 140 per equity share (including a share premium of Rs. 130 per equity share) (Issue Price) aggregating up to Rs. 152.46 crores (Issue). The issue shall constitutes 25.06% of the fully-diluted post- issue paid-up equity share capital of the company.The face value of equity shares is Rs. 10 each. The issue price is 14 times the face value of the equity shares.
Investment in VASPL for part financing its capital expenditure. Requirements in relation to the setting up of the proposed facility. Investment in VASPL for fuding its working capital requirements of VASPL. General corporate purposes.
Valiant Laboratories Ltd, C-101 247 Park, L B S Marg, Vikhroli West, Mumbai-400083
Phone - 91-22-49186000
Fax - 91-22-49186060
Email - complianceofficer@valiantlabs.in
Website - www.valiantlabs.in
